Ningbo David Medical Device Co., Ltd. (SHE:300314)
China · Delayed Price · Currency is CNY 14.60
-0.37 (-2.47%)
Nov 13, 2026, 3:04 PM CST
SHE:300314 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 612.67 | 584.03 | 527.03 | 618.3 | 506.04 | 474.13 |
Revenue Growth | 18.56% | 10.82% | -14.76% | 22.18% | 6.73% | 3.18% |
Gross Profit Gross Profit Growth | 302.73 | 311.02 | 293.55 | 354.68 | 295.76 | 288.88 |
Operating Income Operating Income Growth | 69.64 | 71.06 | 60.39 | 127.25 | 85.5 | 65.61 |
Net Income Net Income Growth | 92.13 | 87.05 | 57.26 | 147.61 | 97.36 | 80.21 |
Earnings Per Share EPS Growth | 0.32 | 0.30 | 0.20 | 0.51 | 0.34 | 0.28 |
EPS Growth | 36.59% | 50.00% | -60.78% | 50.00% | 21.43% | -40.43% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Minimally Invasive Surgical Instruments Minimally Invasive Surgical Instruments Growth | 237.33 | 188.69 | 244.95 | 196.77 | - |
Pediatric Care Equipment Pediatric Care Equipment Growth | 325.16 | 323.23 | 358.36 | 298.21 | - |
Other Products Other Products Growth | 21.54 | 15.11 | 14.99 | 11.06 | 48.24 |
Total Total Growth | 584.03 | 527.03 | 618.3 | 506.04 | 474.13 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 646.9 | 669.96 | 675.67 | 791.63 | 741.84 | 687.35 |
Total Debt Total Debt Growth | 4.6 | 6.01 | 8.82 | 13.69 | 14.53 | 0.59 |
Net Cash (Debt) Net Cash Growth | 642.3 | 663.96 | 666.85 | 777.94 | 727.31 | 686.76 |
Net Cash Growth | 9.05% | -0.43% | -14.28% | 6.96% | 5.90% | 1.87% |
Net Cash Per Share Net Cash Per Share Growth | 2.21 | 2.29 | 2.33 | 2.69 | 2.54 | 2.40 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 86.75 | 89.25 | 93.87 | 135.2 | 111.57 | 51.48 |
Capital Expenditures CapEx Growth | -31.89 | -55.03 | -139.69 | -40.39 | -49.78 | -6.53 |
Free Cash Flow Free Cash Flow Growth | 54.86 | 34.22 | -45.82 | 94.81 | 61.79 | 44.95 |
Free Cash Flow Growth | 259.98% | - | - | 53.43% | 37.48% | -60.41% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 49.41% | 53.25% | 55.70% | 57.36% | 58.45% | 60.93% |
Operating Margin | 11.37% | 12.17% | 11.46% | 20.58% | 16.89% | 13.84% |
Pretax Margin | 16.85% | 16.89% | 12.03% | 26.88% | 22.12% | 18.39% |
Profit Margin | 15.04% | 14.91% | 10.87% | 23.87% | 19.24% | 16.92% |
FCF Margin | 8.95% | 5.86% | -8.70% | 15.33% | 12.21% | 9.48% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.080 | 0.080 | 0.087 | 0.180 | 0.150 | 0.100 |
Dividend Per Share Growth | -8.05% | -8.05% | -51.67% | 20.00% | 50.00% | -33.33% |
Dividend Yield | 0.55% | 0.64% | 0.77% | 1.19% | 1.16% | 0.73% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 45.98 | 41.62 | 56.63 | 29.54 | 38.40 | 48.83 |
Forward PE | - | 16.08 | 16.08 | 18.13 | 40.84 | 40.84 |
P/FCF Ratio | 76.65 | 105.87 | - | 45.99 | 60.50 | 87.14 |
PS Ratio | 6.86 | 6.20 | 6.15 | 7.05 | 7.39 | 8.26 |